Birdwatch Note Rating
2023-04-18 15:15:38 UTC - NOT_HELPFUL
Rated by Participant: C73B71748088561280292538FF5A03FD29CBD76D6C91015DD4E4E5E33302D43A
Participant Details
Original Note:
A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study
All Note Details